Opportunity Information: Apply for RFA RM 22 011
The Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed) is a National Institutes of Health (NIH) funding opportunity (RFA-RM-22-011) that supports the creation of new tools and technologies aimed at improving how scientists find, measure, and interpret somatic variants across many kinds of human tissues. Somatic variants are genetic changes that arise after conception and can be present in only a subset of a persons cells, meaning they may not show up in standard genetic tests that focus on inherited (germline) DNA. The broader SMaHT Network exists to make it easier to discover new biology and identify disease mechanisms driven by these tissue-specific or cell-specific genomic changes, especially where current methods lack sensitivity, accuracy, or scalability.
This FOA focuses specifically on Technology and Tools Development Projects that will produce the next generation of capabilities for detecting and characterizing somatic mosaicism in diverse tissue contexts. In practical terms, the funded work is expected to push beyond routine approaches and address the technical barriers that make somatic variant discovery hard, such as low variant allele fractions, sequencing artifacts, sample quality issues, tissue heterogeneity, and the need to compare signals across multiple tissue types. Projects may include new experimental assays, improved sample processing methods, measurement platforms, computational pipelines, analytical frameworks, or integrated workflows that increase sensitivity, specificity, and reproducibility when calling somatic variants. The emphasis is on enabling the SMaHT Network mission, meaning the deliverables should be broadly useful for studying somatic variation across human tissues rather than being narrowly tailored to a single lab setup.
The award mechanism is a cooperative agreement, indicating that NIH expects substantial scientific or programmatic involvement during the project period. The activity category is Health, and the CFDA number listed is 93.310. The funding instrument uses the UG3/UH3 structure, which is commonly designed as a phased approach: an initial milestone-driven stage (UG3) that supports early development, optimization, and feasibility work, followed by a second stage (UH3) that supports expanded development, refinement, and readiness for broader use once predefined milestones are met. The FOA explicitly states Clinical Trial Not Allowed, so applications must stay within tool and technology development and cannot propose a clinical trial as defined by NIH.
Eligibility is broad and includes many types of applicants across the public, private, and nonprofit sectors. Eligible applicants listed include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other entities. The FOA also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This broad eligibility signals an intent to draw in diverse technical expertise and to encourage participation from institutions and communities that are often underrepresented in large biomedical research networks.
Key administrative details from the source information include an original closing date of July 8, 2022, and a creation date of February 23, 2022. The listing does not provide an award ceiling or an expected number of awards in the provided fields. Overall, the opportunity is best understood as a tool-building initiative within a larger NIH network, aimed at producing robust, shareable, and scalable technologies that make somatic mosaicism easier to detect and study across many human tissues, ultimately enabling new insights into biology and disease mechanisms that are missed when focusing only on inherited genetic variation.Apply for RFA RM 22 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
- This funding opportunity was created on 2022-02-23.
- Applicants must submit their applications by 2022-07-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Previous opportunity: BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 22 011
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 22 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 22 009 Funding Number: RFA RM 22 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed) Apply for RFA RM 22 010 Funding Number: RFA RM 22 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed) Apply for RFA AI 22 012 Funding Number: RFA AI 22 012 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) Apply for RFA RM 22 013 Funding Number: RFA RM 22 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 22 012 Funding Number: RFA RM 22 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 015 Funding Number: RFA AG 23 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 012 Funding Number: RFA AG 23 012 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 013 Funding Number: RFA AG 23 013 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 010 Funding Number: RFA AG 23 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 011 Funding Number: RFA AG 23 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 22 128 Funding Number: PAR 22 128 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional) Apply for PAR 22 122 Funding Number: PAR 22 122 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| The Role of Dentistry in the Prevention of Opioid Drug Misuse and Abuse (UG3/UH3 Clinical Trial Optional) Apply for RFA DE 23 010 Funding Number: RFA DE 23 010 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Apply for PAR 22 119 Funding Number: PAR 22 119 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 003 Funding Number: RFA DE 23 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research at the Intersection of Oral and Mental Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 002 Funding Number: RFA DE 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional) Apply for PAR 22 107 Funding Number: PAR 22 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed) Apply for RFA OD 22 003 Funding Number: RFA OD 22 003 Agency: National Institutes of Health Category: Health Funding Amount: $3,800,000 |
| NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) Apply for PAR 22 135 Funding Number: PAR 22 135 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional) Apply for RFA OD 22 004 Funding Number: RFA OD 22 004 Agency: National Institutes of Health Category: Health Funding Amount: $4,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 22 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
